Therapeutic Drug Monitoring of Antidementia Drugs: A Valid Tool for Successful Individual Benefit/Risk Evaluation

被引：0
|
作者：
R. Koeber
H. H. Kluenemann
D. Melchner
E. Haen
机构：
[1] University ofc Regensburg School of Medicine,Clinical Pharmacology/Psychopharmacology, Department of Psychiatry and Psychotherapy
[2] University of Regensburg School of Medicine,Clinical Neuropsychiatric Genetics, Department of Psychiatry and Psychotherapy
来源：
Drug Safety | 2008年 / 31卷
关键词：
High Performance Liquid Chromatography; Memantine; Therapeutic Drug Monitoring; Galantamine; High Performance Liquid Chromatography Method;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：885 / 885
相关论文
共 50 条
  • [1] Therapeutic Drug Monitoring of Antidementia Drugs: A Valid Tool for Successful Individual Benefit/Risk Evaluation
    Koeber, R.
    Kluenemann, H. H.
    Melchner, D.
    Haen, E.
    DRUG SAFETY, 2008, 31 (10) : 902 - 903
  • [2] Therapeutic Drug Monitoring of Antidementia Drugs
    Koeber, Ralf
    Kluenemann, Hans Hermann
    Waimer, Reinhold
    Koestlbacher, Anton
    Doerfelt, Arnett
    Outlaw, Eva
    Melchner, Doris
    Haen, Ekkehard
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 91S - 91S
  • [3] THERAPEUTIC DRUG MONITORING OF ANTIDEMENTIA DRUGS
    Koeber, R.
    Kluenemann, H-H
    Waimer, R.
    Koestlbacher, A.
    Doerfelt, A.
    Melchner, D.
    Haen, E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 : 9 - 9
  • [4] Simultaneous Determination of Antidementia Drugs in Human Plasma for Therapeutic Drug Monitoring
    Noetzli, Muriel
    Choong, Eva
    Ansermot, Nicolas
    Eap, Chin B.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (02) : 227 - 238
  • [5] Evaluation of therapeutic drug monitoring of antiepileptic drugs
    Irshaid, YM
    Hamdi, AA
    Al Homrany, M
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2003, 41 (03) : 126 - 131
  • [6] DRUG-MONITORING - REQUIREMENTS FOR RISK BENEFIT ESTIMATION FOR DRUGS
    SCHONHOFER, PS
    FRESENIUS ZEITSCHRIFT FUR ANALYTISCHE CHEMIE, 1982, 311 (04): : 314 - 314
  • [7] Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
    Antonio Vena
    Patricia Muñoz
    Miriam Mateos
    Jesus Guinea
    Alicia Galar
    Federico Pea
    Ana Alvarez-Uria
    Pilar Escribano
    Emilio Bouza
    Infectious Diseases and Therapy, 2020, 9 : 137 - 149
  • [8] Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
    Vena, Antonio
    Munoz, Patricia
    Mateos, Miriam
    Guinea, Jesus
    Galar, Alicia
    Pea, Federico
    Alvarez-Uria, Ana
    Escribano, Pilar
    Bouza, Emilio
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (01) : 137 - 149
  • [9] Therapeutic drug monitoring as a tool for assessment of drug interaction between lamotrigine and other antiepileptic drugs
    Ben Sassi, M.
    Gaies, E.
    Salouage, I.
    Charfi, R.
    Jebabli, N.
    El Jebari, H.
    Klouz, A.
    Daghfous, R.
    Trabelsi, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 74 - 74
  • [10] Therapeutic drug monitoring: antiarrhythmic drugs
    Campbell, TJ
    Williams, KM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 : 21S - 34S
12345